Beautifully engraved certificate from Morton-Norwich Products, Inc.
no later than 1974. This historic document was printed by the Security-Columbian Banknote Company and has a vignette of an allegorical woman sitting with medical equipment and two globes. This item is hand signed by the Company's President and Secretary and is
at least 31 years old.
1887 – The Norwich Pharmacal Company in Norwich, NY is established, a partnership between Reverend Lafayette Moore and drug store employee Oscar G. Bell.
1893 – Norwich introduces Unguentine to the medical profession as the first antiseptic surgical dressing.
1901 – Mixture Cholera Infantum appears for the first time in a company sales catalog. Its principal use is for infants with severe diarrhea.
1907 – Acetylsalicylic acid (aspirin) tablets are added to the company’s product line.
1919 – Mixture Cholera Infantum is renamed Pepto-Bismol, which is still on the market under that name today.
1920 – Norwich offers approximately 4,000 elixirs, tinctures, syrups, pills, tablets, extracts, suppositories, dressings and surgical instruments in its product line.
1922 – Unguentine is publicly promoted and advertised.
1939 – Norwich Pharmacal stock is listed on the New York Stock Exchange.
1943-45 – Norwich Pharmacal Company is awarded a total of five Army-Navy "E" awards, a recognition of their war effort during World War II.
1969 – The company merges with Morton International, Inc., forming a new corporation, Morton-Norwich Products, Inc.
1982 – The company, now called Norwich Eaton Pharmaceuticals, becomes a wholly owned subsidiary of the Procter & Gamble Company.